Tag: prenatal and newborn genetic testing market outlook

Uncover key drivers, emerging technologies, and competitive movements shaping the prenatal and newborn genetic testing market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Prenatal And Newborn Genetic Testing Market’s size between 2026 and 2030?

The market size for prenatal and newborn genetic testing has experienced rapid growth in recent years. This market is expected to expand from $7.6 billion in 2025 to $8.51 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.0%. The historical growth of this market can be attributed to various factors such as increased awareness of genetic disorders, the expansion of maternal and neonatal healthcare services, the emergence of more institutional screening programs, the greater availability of diagnostic laboratories, and enhancements in the accuracy of genetic testing.

The prenatal and newborn genetic testing market is anticipated to experience substantial expansion over the next few years. This market is projected to reach $13.65 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.6%. The growth during the forecast period can be attributed to the increasing adoption of personalized medicine approaches, a rising demand for early-stage disease detection, the expansion of newborn screening mandates, growing investments in genomics infrastructure, and the increasing use of digital health platforms. Prominent trends expected in this period include the increasing adoption of non-invasive prenatal testing, a rising use of advanced genetic screening panels, the growing integration of AI in genetic risk analysis, the expansion of high-throughput sequencing platforms, and an enhanced focus on the early detection of congenital disorders.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13158&type=smp

Which Drivers Are Shaping Strategic Decisions In The Prenatal And Newborn Genetic Testing Market?

The anticipated expansion of the prenatal and newborn genetic testing market is linked to the increasing occurrence of genetic disorders. These conditions are defined as health issues stemming from alterations or defects in a person’s DNA or genetic makeup. Such testing, conducted both prenatally and in newborns, facilitates the early detection of genetic disorders, frequently prior to symptom onset, allowing medical professionals to implement prompt interventions and treatment approaches. As an illustration, the Centers for Disease Control and Prevention (CDC), a US public health agency, reported in May 2024 that approximately 100,000 individuals in the United States are affected by sickle cell disease (SCD). Over 90% of those impacted are non-Hispanic Black or African American, and an estimated 3%-9% are Hispanic or Latino. Consequently, the growing frequency of genetic disorders is a key driver for the prenatal and newborn genetic testing market.

What Segment Categories Are Covered In The Prenatal And Newborn Genetic Testing Market?

The prenatal and newborn genetic testing market covered in this report is segmented –

1) By Product Type: Consumables, Instruments

2) By Screening: Non-Invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum Screening, Other Screenings

3) By Disease: Down Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia

4) By End User: Hospital, Maternity And Specialty Clinics, Diagnostic Centers

Subsegments:

1) By Consumables: Reagents And Assays, Sample Collection Kits, Test Kits

2) By Instruments: Polymerase Chain Reaction (PCR) Machines, Sequencers, Microarray Analyzers

What Upcoming Trends Are Likely To Define The Future Path Of The Prenatal And Newborn Genetic Testing Market?

Leading companies operating within the prenatal and newborn genetic testing markets are primarily focused on developing innovative screening tests, such as noninvasive prenatal screening tests, enhancing their accessibility and affordability to deliver dependable services to consumers. Noninvasive prenatal screening (NIPS), also known as noninvasive prenatal testing (NIPT), represents a highly advanced and secure genetic screening methodology conducted during pregnancy to assess the likelihood of specific fetal chromosomal abnormalities. As an illustration, in January 2024, Natera, Inc., a genetic testing company based in the US, launched a fetal RhD NIPT designed to determine fetal RhD status, thereby assisting obstetricians in managing patient care during prevalent Rho(D) immune globulin (RhIg) shortages across the nation. This particular test is underpinned by a comprehensive clinical validation study that included more than 650 RhD-negative patients with verified outcomes, achieving a 100% sensitivity and >99% specificity. Furthermore, Natera’s test offers the advantage of early pregnancy performance, supporting timely clinical decisions and improving patient management.

Which Major Industry Participants Are Leading The Prenatal And Newborn Genetic Testing Market Growth?

Major companies operating in the prenatal and newborn genetic testing market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostic Incorporated, Agilent Technologies Inc, Illumina Inc, PerkinElmer Genomics, Quidel Corporation, Bio Rad Laboratories Inc, Qiagen NV, Werfen SA, DiaSorin SpA, BGI Group, Natera Inc, Trinity Biotech plc, Meridian Bioscience Inc, Sekisui Diagnostics, Ariosa Diagnostics Inc, AccuBioTech Co Ltd, Sequenom Inc, Roche Diagnostics International AG

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Prenatal And Newborn Genetic Testing Market?

North America was the largest region in the prenatal and newborn genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Prenatal And Newborn Genetic Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13158&type=smp

Browse Through More Reports Similar to the Global Prenatal And Newborn Genetic Testing Market 2026, By The Business Research Company

Non Invasive Prenatal Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report

Prenatal Testing And Newborn Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the prenatal and newborn genetic testing market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Prenatal And Newborn Genetic Testing Market’s size between 2026 and 2030?

The market size for prenatal and newborn genetic testing has experienced rapid growth in recent years. This market is expected to expand from $7.6 billion in 2025 to $8.51 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.0%. The historical growth of this market can be attributed to various factors such as increased awareness of genetic disorders, the expansion of maternal and neonatal healthcare services, the emergence of more institutional screening programs, the greater availability of diagnostic laboratories, and enhancements in the accuracy of genetic testing.

The prenatal and newborn genetic testing market is anticipated to experience substantial expansion over the next few years. This market is projected to reach $13.65 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.6%. The growth during the forecast period can be attributed to the increasing adoption of personalized medicine approaches, a rising demand for early-stage disease detection, the expansion of newborn screening mandates, growing investments in genomics infrastructure, and the increasing use of digital health platforms. Prominent trends expected in this period include the increasing adoption of non-invasive prenatal testing, a rising use of advanced genetic screening panels, the growing integration of AI in genetic risk analysis, the expansion of high-throughput sequencing platforms, and an enhanced focus on the early detection of congenital disorders.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13158&type=smp

Which Drivers Are Shaping Strategic Decisions In The Prenatal And Newborn Genetic Testing Market?

The anticipated expansion of the prenatal and newborn genetic testing market is linked to the increasing occurrence of genetic disorders. These conditions are defined as health issues stemming from alterations or defects in a person’s DNA or genetic makeup. Such testing, conducted both prenatally and in newborns, facilitates the early detection of genetic disorders, frequently prior to symptom onset, allowing medical professionals to implement prompt interventions and treatment approaches. As an illustration, the Centers for Disease Control and Prevention (CDC), a US public health agency, reported in May 2024 that approximately 100,000 individuals in the United States are affected by sickle cell disease (SCD). Over 90% of those impacted are non-Hispanic Black or African American, and an estimated 3%-9% are Hispanic or Latino. Consequently, the growing frequency of genetic disorders is a key driver for the prenatal and newborn genetic testing market.

What Segment Categories Are Covered In The Prenatal And Newborn Genetic Testing Market?

The prenatal and newborn genetic testing market covered in this report is segmented –

1) By Product Type: Consumables, Instruments

2) By Screening: Non-Invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum Screening, Other Screenings

3) By Disease: Down Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia

4) By End User: Hospital, Maternity And Specialty Clinics, Diagnostic Centers

Subsegments:

1) By Consumables: Reagents And Assays, Sample Collection Kits, Test Kits

2) By Instruments: Polymerase Chain Reaction (PCR) Machines, Sequencers, Microarray Analyzers

What Upcoming Trends Are Likely To Define The Future Path Of The Prenatal And Newborn Genetic Testing Market?

Leading companies operating within the prenatal and newborn genetic testing markets are primarily focused on developing innovative screening tests, such as noninvasive prenatal screening tests, enhancing their accessibility and affordability to deliver dependable services to consumers. Noninvasive prenatal screening (NIPS), also known as noninvasive prenatal testing (NIPT), represents a highly advanced and secure genetic screening methodology conducted during pregnancy to assess the likelihood of specific fetal chromosomal abnormalities. As an illustration, in January 2024, Natera, Inc., a genetic testing company based in the US, launched a fetal RhD NIPT designed to determine fetal RhD status, thereby assisting obstetricians in managing patient care during prevalent Rho(D) immune globulin (RhIg) shortages across the nation. This particular test is underpinned by a comprehensive clinical validation study that included more than 650 RhD-negative patients with verified outcomes, achieving a 100% sensitivity and >99% specificity. Furthermore, Natera’s test offers the advantage of early pregnancy performance, supporting timely clinical decisions and improving patient management.

Which Major Industry Participants Are Leading The Prenatal And Newborn Genetic Testing Market Growth?

Major companies operating in the prenatal and newborn genetic testing market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostic Incorporated, Agilent Technologies Inc, Illumina Inc, PerkinElmer Genomics, Quidel Corporation, Bio Rad Laboratories Inc, Qiagen NV, Werfen SA, DiaSorin SpA, BGI Group, Natera Inc, Trinity Biotech plc, Meridian Bioscience Inc, Sekisui Diagnostics, Ariosa Diagnostics Inc, AccuBioTech Co Ltd, Sequenom Inc, Roche Diagnostics International AG

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Prenatal And Newborn Genetic Testing Market?

North America was the largest region in the prenatal and newborn genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Prenatal And Newborn Genetic Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13158&type=smp

Browse Through More Reports Similar to the Global Prenatal And Newborn Genetic Testing Market 2026, By The Business Research Company

Non Invasive Prenatal Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report

Prenatal Testing And Newborn Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the prenatal and newborn genetic testing market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Prenatal And Newborn Genetic Testing Market’s size between 2026 and 2030?

The market size for prenatal and newborn genetic testing has experienced rapid growth in recent years. This market is expected to expand from $7.6 billion in 2025 to $8.51 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.0%. The historical growth of this market can be attributed to various factors such as increased awareness of genetic disorders, the expansion of maternal and neonatal healthcare services, the emergence of more institutional screening programs, the greater availability of diagnostic laboratories, and enhancements in the accuracy of genetic testing.

The prenatal and newborn genetic testing market is anticipated to experience substantial expansion over the next few years. This market is projected to reach $13.65 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.6%. The growth during the forecast period can be attributed to the increasing adoption of personalized medicine approaches, a rising demand for early-stage disease detection, the expansion of newborn screening mandates, growing investments in genomics infrastructure, and the increasing use of digital health platforms. Prominent trends expected in this period include the increasing adoption of non-invasive prenatal testing, a rising use of advanced genetic screening panels, the growing integration of AI in genetic risk analysis, the expansion of high-throughput sequencing platforms, and an enhanced focus on the early detection of congenital disorders.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13158&type=smp

Which Drivers Are Shaping Strategic Decisions In The Prenatal And Newborn Genetic Testing Market?

The anticipated expansion of the prenatal and newborn genetic testing market is linked to the increasing occurrence of genetic disorders. These conditions are defined as health issues stemming from alterations or defects in a person’s DNA or genetic makeup. Such testing, conducted both prenatally and in newborns, facilitates the early detection of genetic disorders, frequently prior to symptom onset, allowing medical professionals to implement prompt interventions and treatment approaches. As an illustration, the Centers for Disease Control and Prevention (CDC), a US public health agency, reported in May 2024 that approximately 100,000 individuals in the United States are affected by sickle cell disease (SCD). Over 90% of those impacted are non-Hispanic Black or African American, and an estimated 3%-9% are Hispanic or Latino. Consequently, the growing frequency of genetic disorders is a key driver for the prenatal and newborn genetic testing market.

What Segment Categories Are Covered In The Prenatal And Newborn Genetic Testing Market?

The prenatal and newborn genetic testing market covered in this report is segmented –

1) By Product Type: Consumables, Instruments

2) By Screening: Non-Invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum Screening, Other Screenings

3) By Disease: Down Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia

4) By End User: Hospital, Maternity And Specialty Clinics, Diagnostic Centers

Subsegments:

1) By Consumables: Reagents And Assays, Sample Collection Kits, Test Kits

2) By Instruments: Polymerase Chain Reaction (PCR) Machines, Sequencers, Microarray Analyzers

What Upcoming Trends Are Likely To Define The Future Path Of The Prenatal And Newborn Genetic Testing Market?

Leading companies operating within the prenatal and newborn genetic testing markets are primarily focused on developing innovative screening tests, such as noninvasive prenatal screening tests, enhancing their accessibility and affordability to deliver dependable services to consumers. Noninvasive prenatal screening (NIPS), also known as noninvasive prenatal testing (NIPT), represents a highly advanced and secure genetic screening methodology conducted during pregnancy to assess the likelihood of specific fetal chromosomal abnormalities. As an illustration, in January 2024, Natera, Inc., a genetic testing company based in the US, launched a fetal RhD NIPT designed to determine fetal RhD status, thereby assisting obstetricians in managing patient care during prevalent Rho(D) immune globulin (RhIg) shortages across the nation. This particular test is underpinned by a comprehensive clinical validation study that included more than 650 RhD-negative patients with verified outcomes, achieving a 100% sensitivity and >99% specificity. Furthermore, Natera’s test offers the advantage of early pregnancy performance, supporting timely clinical decisions and improving patient management.

Which Major Industry Participants Are Leading The Prenatal And Newborn Genetic Testing Market Growth?

Major companies operating in the prenatal and newborn genetic testing market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostic Incorporated, Agilent Technologies Inc, Illumina Inc, PerkinElmer Genomics, Quidel Corporation, Bio Rad Laboratories Inc, Qiagen NV, Werfen SA, DiaSorin SpA, BGI Group, Natera Inc, Trinity Biotech plc, Meridian Bioscience Inc, Sekisui Diagnostics, Ariosa Diagnostics Inc, AccuBioTech Co Ltd, Sequenom Inc, Roche Diagnostics International AG

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Prenatal And Newborn Genetic Testing Market?

North America was the largest region in the prenatal and newborn genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Prenatal And Newborn Genetic Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13158&type=smp

Browse Through More Reports Similar to the Global Prenatal And Newborn Genetic Testing Market 2026, By The Business Research Company

Non Invasive Prenatal Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report

Prenatal Testing And Newborn Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Projected Valuation Of The Prenatal And Newborn Genetic Testing Market In The Coming Years?

The market size for prenatal and newborn genetic testing has seen a swift surge in recent years. Predictions suggest an increase from $6.68 billion in 2024 to an impressive $7.6 billion in 2025, showing a compound annual growth rate (CAGR) of 13.7%. The phenomenal growth recorded in the past can be linked to advancements in non-invasive prenatal tests, a rise in maternal age, backing from government and healthcare policies, and a rising patient demand for early detection.

A significant expansion is predicted in the prenatal and newborn genetic testing market in the upcoming years. The growth is anticipated to hit $12.07 billion by 2029, with a compound annual growth rate (CAGR) of 12.3%. Factors such as increased genetic test panels, heightened awareness about maternal health, guidelines for prenatal and newborn screening, a rising focus on rare illnesses, and ethical and regulatory considerations contribute to this expected growth. During this forecast period, trends such as non-invasive prenatal testing (NIPT), whole genome sequencing (WGS), whole exome sequencing, the integration of artificial intelligence (AI), preimplantation genetic testing (PGT) and direct-to-consumer genetic testing, are set to emerge.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13158&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Prenatal And Newborn Genetic Testing Market?

The progression of prenatal and newborn genetic testing markets is projected to be fueled by governmental programs and assistance towards prenatal examinations and newborn genetic assessments. Governmental programs typically outline distinct operations, policies, or projects employed by governmental bodies at various levels – local, regional, national – to address specific issues, achieve certain objectives, or enhance the living standards of its populace. These programs meant for prenatal and newborn genetic analysis aids citizens by assisting in the detection of genetic anomalies or disorders in unborn children during gestation or in infants shortly after their birth. For example, the Australian government in June 2022 sanctioned $1.3 million per annum for the newborn testing program in New South Wales (NSW), a state on Australia’s eastern flank. This program provides free tests for severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA), which includes newborn genetic evaluation and screening, to every newborn in the state. An estimated 100,000 infants would be beneficiaries of these tests annually, potentially saving up to 13 infants who are suspected to have these genetic diseases. Hence, governmental programs and backing for prenatal examinations and newborn genetic assessments act as catalysts for the growth of the prenatal and newborn genetic testing markets.

Which Sub-Segments Are Driving Growth Within The Prenatal And Newborn Genetic Testing Market?

The prenatal and newborn genetic testingmarket covered in this report is segmented –

1) By Product Type: Consumables; Instruments

2) By Screening: Non-Invasive Prenatal Testing; Chronic Villus Sampling; Amniocentesis; Maternal Serum Screening; Other Screenings

3) By Disease: Down Syndrome; Phenylketonuria; Cystic Fibrosis; Sickle Cell Anemia

4) By End User: Hospital; Maternity And Specialty Clinics; Diagnostic Centers

Subsegments:

1) By Consumables: Reagents And Assays; Sample Collection Kits; Test Kits

2) By Instruments: Polymerase Chain Reaction (PCR) Machines; Sequencers; Microarray Analyzers

What Current And Upcoming Trends Are Shaping The Prenatal And Newborn Genetic Testing Market?

Major firms in the marketplace for prenatal and neonatal genetic tests are focusing their efforts on developing cutting-edge screening examinations, such as noninvasive prenatal exams, which are more affordable and accessible, and promise dependable service for clients. Noninvasive prenatal screenings (NIPS), alternatively known as noninvasive prenatal tests (NIPT), are sophisticated and secure genetic screening procedures employed during gestation to evaluate the potential risk of certain chromosomal disorders in the fetus. For instance, Juno Diagnostics Inc., a medical technology firm based in the US, introduced ‘Juno Hazel’ in November 2022, a noninvasive prenatal screening test capable of identifying chromosomal abnormalities and providing clinical information. The test employs a sample collection kit, eradicates the need for phlebotomy, and escalates accessibility. The firm intends to supply educational materials and tailored genetic counseling support by teaming up with physicians and genetic advisors.

Which Players Are Shaping The Competitive Landscape Of The Prenatal And Newborn Genetic Testing Market?

Major companies operating in the prenatal and newborn genetic testing market report are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Quest Diagnostic Incorporated, Agilent Technologies Inc., Grifols S.A., Terumo Corporation, Illumina Inc., PerkinElmer Genomics, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen NV, Werfen S.A., DiaSorin S.p.A, Nova Biomedical, BGI Group, Natera Inc., Trinity Biotech PLC, Meridian Bioscience Inc., Sekisui Diagnostics, Chembio Diagnostics, PTS Diagnostics, Ariosa Diagnostics Inc., AccuBioTech Co. Ltd., Sequenom Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

How Do Regional Dynamics Influence The Prenatal And Newborn Genetic Testing Market Performance?

North America was the largest region in the prenatal and newborn genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=13158&type=smp

Browse Through More Reports Similar to the Global Prenatal And Newborn Genetic Testing Market 2025, By The Business Research Company

Endotoxin Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/endotoxin-testing-global-market-report

Heavy Metal Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/heavy-metal-testing-global-market-report

5G Device Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/5g-device-testing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Prenatal And Newborn Genetic Testing Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The prenatal and newborn genetic testing market has seen substantial expansion in recent years. Its valuation is anticipated to increase from $6.68 billion in 2024 to $7.6 billion in 2025, achieving a compound annual growth rate (CAGR) of 13.7%. This historical expansion can be attributed to enhancements in non-invasive prenatal testing, a rise in maternal age, supportive governmental and healthcare policies, and patient desire for early detection.

The prenatal and newborn genetic testing market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $12.07 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 12.3%. Factors contributing to this growth during the forecast period include the broadening of genetic test panels, increased awareness regarding maternal health, established prenatal and newborn screening protocols, a heightened emphasis on rare diseases, and evolving ethical and regulatory frameworks. Key trends anticipated during the forecast timeframe encompass non-invasive prenatal testing (NIPT), whole genome sequencing (WGS) and whole exome sequencing, the incorporation of artificial intelligence (AI), preimplantation genetic testing (PGT), and direct-to-consumer genetic testing.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13158&type=smp

Which Drivers Are Shaping The Prenatal And Newborn Genetic Testing Industry’s Market Share?

Future expansion of the prenatal and newborn genetic testing markets is anticipated due to government programs and assistance for prenatal testing and newborn genetic screening. These initiatives encompass particular actions, programs, policies, or projects executed by governmental bodies at local, regional, or national tiers, aimed at resolving issues, accomplishing objectives, or fostering public welfare. Specifically, government efforts in prenatal and newborn genetic testing aid the population by facilitating the detection of genetic conditions or abnormalities in fetuses during gestation or in infants soon after delivery. An example of this is the Australian government’s annual commitment of $1.3 million in June 2022 to the New South Wales (NSW), a state on Australia’s east coast, newborn screening program. This funding provides complimentary tests for severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA), encompassing newborn genetic testing and screening, for all infants born in the state. Approximately 100,000 babies are expected to receive these screening tests annually, potentially saving the lives of up to 13 newborns who might otherwise suffer from these genetic conditions. Consequently, government initiatives and backing for prenatal testing and newborn genetic screening are key drivers for the prenatal and newborn genetic testing markets.

What Are The Major Segment Types Covered In The Prenatal And Newborn Genetic Testing Market?

The prenatal and newborn genetic testingmarket covered in this report is segmented –

1) By Product Type: Consumables; Instruments

2) By Screening: Non-Invasive Prenatal Testing; Chronic Villus Sampling; Amniocentesis; Maternal Serum Screening; Other Screenings

3) By Disease: Down Syndrome; Phenylketonuria; Cystic Fibrosis; Sickle Cell Anemia

4) By End User: Hospital; Maternity And Specialty Clinics; Diagnostic Centers

Subsegments:

1) By Consumables: Reagents And Assays; Sample Collection Kits; Test Kits

2) By Instruments: Polymerase Chain Reaction (PCR) Machines; Sequencers; Microarray Analyzers

What Key Innovation Trends Are Fueling Advancements In The Prenatal And Newborn Genetic Testing Market?

Leading firms in the prenatal and newborn genetic testing sectors are prioritizing the creation of cutting-edge screening methods, such as noninvasive prenatal screening, that offer enhanced accessibility and cost-effectiveness to deliver dependable services to consumers. Noninvasive prenatal screening (NIPS), also known as noninvasive prenatal testing (NIPT), represents a sophisticated and secure genetic screening technique utilized during gestation to evaluate the likelihood of particular fetal chromosomal irregularities. An example of this is Juno Diagnostics Inc., a US-based healthcare technology company, which introduced Juno Hazel in November 2022. This noninvasive prenatal screening test is designed to identify chromosomal aberrations and deliver relevant clinical information. This test utilizes a sample collection kit, thereby removing the necessity for phlebotomy and enhancing its overall accessibility. Furthermore, the company intends to provide educational materials and individualized genetic counseling assistance through collaborations with physicians and genetic counselors.

Which Key Market Players Are Investing In Expansion And Innovation Of Prenatal And Newborn Genetic Testing Market?

Major companies operating in the prenatal and newborn genetic testing market report are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Quest Diagnostic Incorporated, Agilent Technologies Inc., Grifols S.A., Terumo Corporation, Illumina Inc., PerkinElmer Genomics, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen NV, Werfen S.A., DiaSorin S.p.A, Nova Biomedical, BGI Group, Natera Inc., Trinity Biotech PLC, Meridian Bioscience Inc., Sekisui Diagnostics, Chembio Diagnostics, PTS Diagnostics, Ariosa Diagnostics Inc., AccuBioTech Co. Ltd., Sequenom Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

Which Region Is Projected To Lead The Prenatal And Newborn Genetic Testing Market During The Forecast Period?

North America was the largest region in the prenatal and newborn genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Prenatal And Newborn Genetic Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13158&type=smp

Browse Through More Reports Similar to the Global Prenatal And Newborn Genetic Testing Market 2025, By The Business Research Company

Endotoxin Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/endotoxin-testing-global-market-report

Heavy Metal Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/heavy-metal-testing-global-market-report

5G Device Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/5g-device-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Prenatal And Newborn Genetic Testing Market Growth in 2025?

The market size of prenatal and newborn genetic testing has seen a fast-paced growth in the past few years. Its growth from $6.68 billion in 2024 to $7.61 billion in 2025, with a compound annual growth rate (CAGR) of 13.9%, reflects this upward trend. The factors that have contributed to the growth during the historical period include enhanced non-invasive prenatal testing, a rise in maternal age, governmental assistance and health care regulations, along with patient preferances for early diagnosis.

What Is the Forecast for the Prenatal And Newborn Genetic Testing Market Size Through 2029?

The market size of prenatal and newborn genetic testing is projected to witness accelerated expansion in the forthcoming years. By 2029, it is anticipated to reach $12.04 billion, with a compound annual growth rate (CAGR) of 12.1%. This growth is expected to be driven by factors such as the enhancement of genetic test panels, increased awareness about maternal health, guidelines for prenatal and newborn screening, a heightened focus on uncommon diseases, and ethical and regulatory considerations. Noteworthy trends throughout this forecast period are likely to include non-invasive prenatal testing (NIPT), whole genome sequencing (WGS) and whole exome sequencing, artificial intelligence (AI) integration, preimplantation genetic testing (PGT), and direct-to-consumer genetic testing.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13158&type=smp

What are the Key Market Players in Prenatal And Newborn Genetic Testing Market and How They’re Evolving?

Major companies operating in the prenatal and newborn genetic testing market report are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Quest Diagnostic Incorporated, Agilent Technologies Inc., Grifols S.A., Terumo Corporation, Illumina Inc., PerkinElmer Genomics, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen NV, Werfen S.A., DiaSorin S.p.A, Nova Biomedical, BGI Group, Natera Inc., Trinity Biotech PLC, Meridian Bioscience Inc., Sekisui Diagnostics, Chembio Diagnostics, PTS Diagnostics, Ariosa Diagnostics Inc., AccuBioTech Co. Ltd., Sequenom Inc.

What Are the Primary Growth Drivers in the Prenatal And Newborn Genetic Testing Market?

The expansion of the prenatal and newborn genetic testing markets is likely to be driven by government initiatives and support for prenatal testing and newborn genetic screening. Such initiatives from the government can come in the form of particular actions, programs, projects, or policies, aimed at tackling certain issues, achieving defined goals, or improving citizens’ wellbeing. These initiatives, specifically focused on prenatal and newborn genetic testing, help the populace by detecting genetic abnormalities in fetuses during pregnancy, or in newborns shortly after they’re born. For example, in June 2022, the government of Australia committed an annual $1.3 million to the newborn screening program in New South Wales (NSW), a state on Australia’s east coast. The program provides free tests for severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA), including the newborn genetic testing and screening, to every newborn in the state. With the capacity to provide screening tests to approximately 100,000 babies per year, this program can potentially save up to 13 newborns likely to have these genetic disorders. The growth of the prenatal and newborn genetic testing markets is thus facilitated by government initiatives and support for these kinds of testing and screening.

Prenatal And Newborn Genetic Testing Market Driver: Surge in Genetic Disorder Rates Spurs Prenatal And Newborn Genetic Testing Market Growth

 

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13158&type=smp

What Are the Leading Segments in the Global Prenatal And Newborn Genetic Testing Industry?

The prenatal and newborn genetic testing market covered in this report is segmented –

1) By Product Type: Consumables, Instruments

2) By Screening: Non-Invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum Screening, Other Screenings

3) By Disease: Down Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia

4) By End User: Hospital, Maternity And Specialty Clinics, Diagnostic Centers

Subsegments:

1) By Consumables: Reagents And Assays, Sample Collection Kits, Test Kits

2) By Instruments: Polymerase Chain Reaction (PCR) Machines, Sequencers, Microarray Analyzers

What Are the Key Market Trends in the Prenatal And Newborn Genetic Testing Industry?

Principal businesses in the prenatal and newborn genetic testing arena are concentrating their efforts on launching innovative screening tests, such as noninvasive prenatal screening tests. They are aiming to improve both accessibility and affordability, ensuring dependable services for customers. Noninvasive prenatal screening (NIPS) or noninvasive prenatal testing (NIPT) is an advanced and secure genetic screening approach used during pregnancy to evaluate the risk of specific fetal chromosomal abnormalities. For instance, in November 2022, Juno Diagnostics Inc., a healthcare technology firm based in the United States, unveiled Juno Hazel. This is a noninvasive prenatal screening test designed to identify chromosomal deviations and offer clinical context. By leveraging a sample collection kit, the test eliminates the requirement for phlebotomy and enhances accessibility. Furthermore, the company intends to provide educational materials and individualized genetic counseling support through collaborations with physicians and genetic counselors.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

What Is the Regional Outlook for the Prenatal And Newborn Genetic Testing Market?

North America was the largest region in the prenatal and newborn genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13158

This Report Delivers Insight On:

1. How big is the prenatal and newborn genetic testing market, and how is it changing globally?

2. Who are the major companies in the prenatal and newborn genetic testing market, and how are they performing?

3. What are the key opportunities and risks in the prenatal and newborn genetic testing market right now?

4. Which products or customer segments are growing the most in the prenatal and newborn genetic testing market?

5. What factors are helping or slowing down the growth of the prenatal and newborn genetic testing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model